NorthStar Medical Radioisotopes Revenue and Competitors
Estimated Revenue & Valuation
- NorthStar Medical Radioisotopes's estimated annual revenue is currently $46.2M per year.
- NorthStar Medical Radioisotopes's estimated revenue per employee is $201,000
- NorthStar Medical Radioisotopes's total funding is $117.5M.
Employee Data
- NorthStar Medical Radioisotopes has 230 Employees.
- NorthStar Medical Radioisotopes grew their employee count by 20% last year.
NorthStar Medical Radioisotopes Competitors & Alternatives
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.4M | 151 | 0% | N/A | N/A |
#2 | $56.3M | 280 | N/A | N/A | N/A |
#3 | $0.8M | 4 | 0% | N/A | N/A |
#4 | $34M | 169 | -8% | N/A | N/A |
#5 | $3.2M | 16 | N/A | N/A | N/A |
#6 | $21.1M | 105 | -13% | N/A | N/A |
#7 | $2.6M | 13 | N/A | N/A | N/A |
#8 | $21.1M | 105 | -9% | N/A | N/A |
#9 | $52.5M | 261 | 40% | $672.1M | N/A |
#10 | $46.2M | 230 | 20% | $117.5M | N/A |
What Is NorthStar Medical Radioisotopes?
NorthStar® Medical Radioisotopes is a nuclear medicine technology company dedicated to transforming the ways that medical radioisotopes are produced and distributed around the world. We are committed to providing the United States with reliable and environmentally friendly radioisotope supply solutions to meet the needs of patients and to advance clinical research. Our first product is the FDA-approved RadioGenix® System, a first of its kind, innovative platform technology for the processing of domestically sourced molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), which is currently the most widely used diagnostic radioisotope for medical purposes. Based in Beloit, Wis., NorthStar Medical Radioisotopes, LLC is a wholly-owned subsidiary of NorthStar Medical Technologies, LLC.
keywords:Biotechnology,Healthcare,Hospitality,Medical Devices,Pharmaceuticals$117.5M
Total Funding
230
Number of Employees
$46.2M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NorthStar Medical Radioisotopes News
... in Nuclear Medicine Market Detailed In New Research Report 2022 | Progenics Pharmaceuticals, Inc., NorthStar Medical Radioisotopes LLC,...
... and strategies are Eczacýbaþý-Monrol Nuclear Products, NorthStar Medical Radioisotopes, Smith & Nephew plc., Lantheus Medical Imaging,...
NorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company that manufactures and distributes diagnostic and therapeutic...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $54.1M | 234 | 4% | N/A |
#2 | $73.7M | 248 | 3% | N/A |
#3 | $88.5M | 298 | 25% | N/A |
#4 | $116.6M | 518 | 5% | N/A |
#5 | $182.6M | 541 | 2% | N/A |